SARS-CoV-2 VARIANTS GENOME ANALYSIS OF INDONESIAN ISOLATES AND THEIR RESPONSES TO AVAILABLE VACCINES
Main Article Content
Abstract
SARS-CoV-2 is a virus that initially appeared in Wuhan, China, at the end of 2019. In Indonesia, multiple variants of SARS-CoV-2 have been identified, as well as various local variants that are not yet considered to be ‘variants of concern’. Therefore, this investigation is intended to understand the prevalence and epidemiology of the virus, along with detecting the mutations that occur in genes associated with whole-genome-sequences (WGS) isolated in Indonesia. Analyses were performed to investigate SARS-CoV-2 prevalence in Indonesia using data obtained from GISAID.org. Whole-genome sequencing was performed on random samples taken from GISAID.org utilizing the BLAST tool from NCBI. The variants identified in Indonesia are alpha, beta and delta variants, as well as local variants B.1.470 and B.1.466.2. In total there are 9,260 isolated genomes collected in GISAID were located in Indonesia. Using BLAST, the variants were compared with the Wild-Type from Wuhan NC.045512.2. Multiple mutations were observed in the samples. The results from whole-genome sequencing of variants isolated in Indonesia have found that multiple mutations have occurred in genes of the SARS-CoV-2 virus and it caused alterations in the characteristics of the virus and may affect vaccine efficacy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Cevik M, Grubaugh ND, Iwasaki A, et al. (2021) COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants. Cell. 184(20):5077-5081. doi: https://doi.org/10.1016/j.cell.2021.09.010.
Chrysostomou AC, Vrancken B, Koumbaris G, et al. (2021) A Comprehensive Mo-lecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus From April 2020 to January 2021: Ev-idence of a Highly Polyphyletic and Evolving Epidemic. Viruses 13:1098. doi: 10.3390/v13061098.
Clinic M (2021) Coronavirus disease 2019 (COVID-19). Available from: https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963
Fibriani A, Stephanie R, Alfiantie AA, et al. (2021) Analysis of SARS-CoV- 2 Ge-nomes from West Java, Indonesia. Vi-ruses 13(10):2097. doi: https://doi.org/10.3390/v13102097.
Liu Y, Liu J, Johnson BA, et al. (2021) Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha vari-ant. BioRxiv. doi: https://doi.org/10.1101%2F2021.08.12.456173.
Lucas C, Vogels CB, Yildirim I., et al. (2021) Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature. 1-7. doi: https://doi.org/10.1038/s41586-021-04085-y.
Mittal A, Manjunath K, Ranjan RK, et al. (2020) COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLoS pathogens 16(8):e1008762. doi: https://doi.org/10.1371/journal.ppat.1008762.
Mohammadi M, Shayestehpour M, Mirzaei H (2021) The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vac-cines. Brazilian Journal of Infectious Diseases. 25. doi: https://doi.org/10.1016/j.bjid.2021.101606.
Ostrov DA (2021) Structural Consequences of Variation in SARS- CoV-2 B.1.1.7. J. Cell Immunol. 3:103–108. doi:10.33696/immunology.3.085.
Rees-Spear C, Muir L, Griffith SA, et al. (2021) The effect of spike mutations on SARS-CoV-2 neutralization. Cell reports. 34(12):108890. doi: https://doi.org/10.1016/j.celrep.2021.108890.
Sanches PR, Charlie-Silva I, Braz HL, et al. (2021) Recent advances in SARS-CoV-2 Spike protein and RBD muta-tions comparison between new vari-ants Alpha (B. 1.1. 7, United King-dom), Beta (B. 1.351, South Africa), Gamma (P. 1, Brazil) and Delta (B. 1.617. 2, India). Journal of Virus Erad-ication. 100054. doi: 10.1016/j.jve.2021.100054.
Socher E, Conrad M, Heger L, et al. (2021) Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide. Biomedi-cines 9: 525. doi: 10.3390/biomedicines9050525.
Starr TN, Greaney AJ, Hilton SK, et al. (2020) Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Do-main Reveals Constraints on Folding and ACE2 Binding. Cell. 182:1295–1310.e1220. doi:10.1016/j.cell.2020.08.012.
Tegally H, Wilkinson E, Giovanetti M, et al. (2021) Detection of a SARS-CoV-2 variant of concern in South Africa. Na-ture 592(7854):438-443. doi:10.1038/s41586-021-03402-9.
Timmers LFSM, Peixoto JV, Ducati RG (2021) SARS-CoV-2 mutations in Brazil: from genomics to putative clin-ical conditions. Sci Rep. 11: 11998. doi: 10.1038/s41598-021-91585-6.
Tregoning JS, Flight KE, Higham SL, et al. (2021) Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature Reviews Immu-nology. 1-11. doi: 10.1038/s41577-021-00592-1.
WHO (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on covid-19-final-report.pdf#:~:text=People with COVID-19. mild disease and recover
Wiranti W, Ayun S, Wulan K (2020) Deter-minan Kepatuhan Masyarakat Kota Depok terhadap Kebijakan Pembata-san Sosial Berskala Besar dalam Pencegahan Covid-19. Jurnal Ke-bijakan Kesehatan Indonesia 9(3):117-124. doi: https://doi.org/10.22146/jkki.58484.
World Health Organization. (n.d.) (2021) Tracking sars-COV-2 variants. World Health Organization. Retrieved De-cember 1:2021. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
Wu A, Peng Y, Huang B, et al. (2020) Ge-nome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host & mi-crobe 27(3):325-328. doi: https://doi.org/10.1016/j.chom.2020.02.001.
Zhao LP, Lybrand TP, Gilbert PB, et al. (2021) Tracking SARS-CoV-2 Spike Protein Mutations in the United State/01 - 2021/03) Using a Statistical Learning Strategy. BioRxiv. doi: 10.2139/ssrn.3844900.
Zhou W, Xu C, Wang P, et al. (2021) N439K variant in spike protein alter the infec-tion efficiency and antigenicity of SARS-CoV-2 based on molecular dy-namics simulation. Frontiers in cell and developmental biology. 2071. doi: https://doi.org/10.3389/fcell.2021.697035.